Related Experiment Video

Updated: Nov 21, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

[HIV in the time of COVID-19 : the meeting between two pandemics]

Olivier Nawej Tshikung1, Hélène Buvelot1, Alexandra Calmy1

  • 1Unité VIH/SIDA, Service des maladies infectieuses, HUG, 1211 Genève 14.

Revue Medicale Suisse
|January 14, 2021
PubMed

Insights

This article examines the impact of COVID-19 on people with HIV, considering their vulnerability and potential protection from antiretroviral therapy. It explores treatment, recovery, prevention, and future HIV therapies in light of the SARS-CoV-2 pandemic.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • The COVID-19 pandemic presents unique challenges for immunocompromised populations.
  • Individuals living with Human Immunodeficiency Virus (HIV) are a key focus due to existing vulnerabilities.

Purpose of the Study:

  • To analyze the potential impact of SARS-CoV-2 infection on people living with HIV.
  • To compare and contrast COVID-19 and HIV in terms of treatment, recovery, and prevention strategies.
  • To review emerging therapeutic approaches for HIV management.

Main Methods:

  • Literature review of existing studies on SARS-CoV-2 and HIV.
  • Comparative analysis of epidemiological and clinical data.
  • Exploration of current and future treatment modalities for both conditions.

Main Results:

  • Assessing the specific risks and outcomes for people with HIV infected with SARS-CoV-2.
  • Identifying commonalities and divergences in managing these dual pandemics.
  • Evaluating the influence of antiretroviral therapy on COVID-19 outcomes in HIV-positive individuals.

Conclusions:

  • Understanding the interplay between HIV and COVID-19 is crucial for public health.
  • Antiretroviral therapy may influence SARS-CoV-2 susceptibility and severity in people with HIV.
  • Further research is needed to optimize prevention and treatment strategies for co-infected individuals and advance HIV therapeutics.

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.7K
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

14.0K

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
608
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.4K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
80
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K